Get all your news in one place
100’s of premium titles. One news app. Zero ads. Just $10 per month.

Merck wins European approval for first-ever Ebola vaccine

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid

(Reuters) - U.S. drugmaker Merck & Co Inc on Monday received approval from the European Commission to market ( its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.

The vaccine, Ervebo, is approved for individuals aged 18 years and older and has already been used under emergency guidelines to try to protect against the spread of a deadly Ebola outbreak in Democratic Republic of Congo.

The shot is also being reviewed by U.S. health regulators and a decision is expected in the first quarter of next year.

The Ebola virus causes hemorrhagic fever and spreads from person to person through direct contact with body fluids. It kills around half of those it infects.

Since the middle of last year, the Congo Ebola outbreak has killed more than 2,100 people, making it the second-largest Ebola outbreak in history, after the 2013-16 epidemic in West Africa that killed more than 11,300.

"The EU is supporting international efforts to combat Ebola on all fronts, from vaccine development to delivering humanitarian aid on the ground," EU Ebola Coordinator Christos Stylianides said in a statement dated Nov. 10.

Merck has said its priority was to get regulatory approval of its Ervebo manufacturing site in Germany so that licensed supply of the vaccine "can be used to support global public health preparedness".

(Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Sriraj Kalluvila)

Related Stories
The Ebola Vaccine Is Now Officially Here With Approval In Europe
In big global health news, the European Commission has granted Merck Sharp and Dohme B.V. marketing authorization in Europe for…
One subscription that gives you access to news from hundreds of sites
WHO prequalifies first Ebola vaccine
Geneva (AFP) - The World Health Organization (WHO) on Tuesday said it had prequalified an Ebola vaccine for the first…
Rollout of Johnson & Johnson Ebola vaccine begins in Congo
GOMA, Congo (Reuters) - Health authorities in eastern Congo have introduced a new Ebola vaccine produced by Johnson Johnson, aid…
Second Ebola vaccine introduced in DR Congo
Goma (DR Congo) (AFP) - The Democratic Republic of Congo on  Thursday introduced a second vaccine to fight a 15-month-old…
U.S. records one new case in measles outbreak
(Reuters) - One new case of measles was reported this weekend in the United States, with the country suffering its…
One subscription that gives you access to news from hundreds of sites
Pneumonia kills a child every 39 seconds, health agencies say
LONDON (Reuters) - Pneumonia killed more than 800,000 babies and young children last year - or one child every 39…